Smiling Biotech ApS Financials, key figures and credit report
Gross profit -81.0 kDKK FY 2025 -159.9% vs 2024
EBIT -81.0 kDKK FY 2025 -159.9% vs 2024
Net debt -75.2 kDKK FY 2025 +84.4% vs 2024
Quick ratio 4.7 FY 2025 -1.1 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 892.98 | 2 157.13 | 1 574.56 | 135.21 | -81.00 |
| EBIT | 892.98 | 2 157.13 | 1 574.56 | 135.21 | -81.00 |
| Other financial income | 32.85 | 622.80 | 253.12 | 115.54 | 26.33 |
| Other financial expenses | - 363.85 | - 905.94 | - 380.97 | -61.27 | -7.41 |
| Net income from associates (fin.) | -54.24 | ||||
| Pre-tax profit | 561.99 | 1 819.74 | 1 446.71 | 189.48 | -62.09 |
| Income taxes | - 173.65 | - 383.67 | - 329.99 | -47.20 | 16.39 |
| Net earnings | 388.34 | 1 436.07 | 1 116.71 | 142.27 | -45.69 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 54.24 | 690.00 | 1 690.00 | ||
| Investments total | 54.24 | 690.00 | 1 690.00 | ||
| Non-current loans receivable | 1 989.78 | 2 126.05 | |||
| Long term receivables total | 1 989.78 | 2 126.05 | |||
| Finished products/goods | 2 033.72 | ||||
| Inventories total | 2 033.72 | ||||
| Current trade debtors | 4 683.00 | 2 499.68 | 780.13 | 129.13 | |
| Current owed by particip. interest comp. | 57.50 | ||||
| Prepayments and accrued income | 533.10 | 3 123.02 | 3 397.73 | 1 503.02 | 402.88 |
| Current other receivables | 39.09 | 6.09 | 29.12 | 0.61 | 9.06 |
| Current deferred tax assets | 269.64 | 155.46 | 464.49 | ||
| Short term receivables total | 5 582.32 | 5 784.25 | 4 671.48 | 1 632.76 | 411.95 |
| Cash and bank deposits | 2 437.68 | 695.31 | 585.34 | 480.52 | 75.16 |
| Cash and cash equivalents | 2 437.68 | 695.31 | 585.34 | 480.52 | 75.16 |
| Balance sheet total (assets) | 8 074.24 | 9 203.27 | 6 946.82 | 4 103.06 | 2 613.15 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 570.00 | ||||
| Retained earnings | - 353.24 | 35.09 | 891.16 | 2 007.88 | 2 015.15 |
| Profit of the financial year | 388.34 | 1 436.07 | 1 116.71 | 142.27 | -45.69 |
| Shareholders equity total | 645.10 | 1 511.16 | 2 047.88 | 2 190.15 | 2 009.46 |
| Provisions | 117.28 | 137.78 | 167.23 | 88.64 | |
| Non-current liabilities total | |||||
| Advances received | 4 136.29 | 4 261.17 | 3 517.77 | 1 543.30 | 410.61 |
| Current trade creditors | 2 826.98 | 3 087.52 | 841.31 | 185.46 | 65.01 |
| Short-term deferred tax liabilities | 106.01 | 18.98 | |||
| Other non-interest bearing current liabilities | 348.59 | 205.64 | 372.62 | 78.14 | 20.46 |
| Current liabilities total | 7 311.86 | 7 554.33 | 4 731.71 | 1 912.91 | 515.06 |
| Balance sheet total (liabilities) | 8 074.24 | 9 203.27 | 6 946.82 | 4 103.06 | 2 613.15 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated